CTD Section 2.7.3 Report
Summary
Section Name:
Summary of Clinical Efficacy [indication]
Section Code:
2.7.3
Module Number:
2
Description:
This section should provide the reviewer with an overall view of the clinical studies that were designed to evaluate efficacy of the product for the indication/s that were tested. For each study, describe the study design, and provide a factual summary of the results obtained. Include a section comparing and contrasting the results of all efficacy studies in humans. Finally, provide a discussion of clinical information relevant to dosing recommendations persistence of efficacy
Submission Timing
As early as initial IND application (see note), completed by marketing application
Last Updated:
August 22, 2025 - 04:45 PM
Required with submission of type
Resources